Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (23023)	10/27/2000 12:20:40 AM
From: Brander	Respond to of 23519

Frostman, I would like to know the 'real deal' about ALIBRA too--very much so. It took me and a lot of other people by surprise, and I am very curious as to what the FDA's concern is. Vivus says they don't know, but I really don't believe that. I don't believe that Vivus would pull their only NDA not knowing what the basic problem is. In the long run, all this won't amount to much if ALISTA is successful, but I still want to know what happened. B